Close Menu

CHICAGO (GenomeWeb) – Sequencing informatics technology developer Edico Genome has closed a $22 million Series B funding round, led by new investor Dell Technologies Capital. All previous venture investors, including Qualcomm Ventures, Axon Ventures, and NuVasive CEO Greg Lucier, participated in this round, San Diego-based Edico said today.

Edico is looking to use the new money to continue development and marketing of Dragen, the company's field-programmable gate array bioinformatics processor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.